Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Assets (2021 - 2023)

Cullinan Therapeutics has reported Return on Assets over the past 3 years, most recently at 0.31% for Q3 2023.

  • Quarterly results put Return on Assets at 0.31% for Q3 2023, down 47.0% from a year ago — trailing twelve months through Sep 2023 was 0.31% (down 47.0% YoY), and the annual figure for FY2022 was 0.22%, up 43.0%.
  • Return on Assets for Q3 2023 was 0.31% at Cullinan Therapeutics, down from 0.27% in the prior quarter.
  • Over the last five years, Return on Assets for CGEM hit a ceiling of 0.2% in Q2 2022 and a floor of 0.31% in Q3 2023.
  • Median Return on Assets over the past 3 years was 0.14% (2021), compared with a mean of 0.06%.
  • Biggest five-year swings in Return on Assets: surged 34bps in 2022 and later tumbled -47bps in 2023.
  • Cullinan Therapeutics' Return on Assets stood at 0.15% in 2021, then soared by 222bps to 0.19% in 2022, then tumbled by -266bps to 0.31% in 2023.
  • The last three reported values for Return on Assets were 0.31% (Q3 2023), 0.27% (Q2 2023), and 0.12% (Q1 2023) per Business Quant data.